Bottom line
What is CVSIX's expense ratio?
CVSIX's expense ratio is 1.26%, or about $126 a year on every $10,000 invested. That is cheaper than 64% of alternatives funds we track (median 1.54%). This share class also charges a front-end sales load of up to 2.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Feb 26, 2026
CVSIX fee table
| Net expense ratio | 1.26% |
|---|---|
| Gross expense ratio | 1.26% |
| Management fee | 0.65% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.15% |
| Acquired fund fees | 0.01% |
| Max front-end sales load | 2.75% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What CVSIX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CVSIX | $400 | $664 | $948 | $1,756 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.26% expense ratio costs roughly $68,200 in lost growth, versus about $81,400 for the median alternatives fund (1.54%).